SLNO
Soleno Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$53.01
+0.00%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 27.09x
- PEG TTM
- —
- Price / book
- 5.57x
- Price / sales
- 9.69x
- Price / cash flow
- 26.14x
Enterprise value
- Enterprise value
- $2.5B
- EV / sales
- 8.81x
- EV / EBITDA
- 24.49x
- EV / EBIT
- 28.62x
- Market cap
- $2.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026